Related Experiment Video
Updated: Mar 12, 2026
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model
Giovanna Turconi1, Debora Scaldaferri2, Marco Fabbri3
1Department of Theoretical and Applied Sciences, University of Insubria, Varese, Italy.
Abstract:
Ribonucleases (RNases) are hydrolytic enzymes endowed with the ability to either process or degrade ribonucleic acids. Among the many biological functions assigned to RNases, a growing attention has been recently devoted to the control of cancer growth, in the attempt to bring novel therapeutic approaches to clinical oncology. Indeed, several enzymes belonging to different ribonuclease families have been reported in the last decade to display a marked oncosuppressive activity in a wide range of experimental models. The human RNASET2 gene, the only member of the highly conserved T2/Rh/S family of endoribonucleolytic enzymes described in our species, has been shown to display oncosuppressive roles in both in vitro and in vivo models representing several human malignancies. In the present study, we extend previous findings obtained in ovarian cancer models to shed further light on the cell-autonomous roles played by this gene in the context of its oncosuppresive role and to show that RNASET2 silencing can significantly affect the transcriptional output in one of the most thoroughly investigated human ovarian cancer cell lines. Moreover, we report for the first time that RNASET2-mediated changes in the cell transcriptome are in part mediated by its apparent ability to affect the cell's microRNA expression pattern.
Insights
The human RNASET2 gene, an enzyme with cancer-suppressing abilities, influences ovarian cancer cell transcription and microRNA patterns. Silencing this gene significantly alters gene expression, offering insights into cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Ribonucleases (RNases) are enzymes that process or degrade ribonucleic acids.
- RNases are increasingly recognized for their potential in cancer therapy due to their oncosuppressive activities.
- The human RNASET2 gene, part of the T2/Rh/S family, exhibits oncosuppressive roles in various cancer models.
Purpose of the Study:
- To investigate the cell-autonomous roles of the RNASET2 gene in ovarian cancer.
- To determine the impact of RNASET2 gene silencing on the transcriptional output of human ovarian cancer cells.
- To explore RNASET2's influence on microRNA expression patterns in ovarian cancer.
Main Methods:
- Gene silencing techniques to reduce RNASET2 expression in ovarian cancer cell lines.
- Transcriptome analysis to assess changes in gene expression following RNASET2 silencing.
- MicroRNA profiling to investigate RNASET2's effect on microRNA expression.
Main Results:
- RNASET2 gene silencing significantly altered the transcriptional output in a human ovarian cancer cell line.
- RNASET2-mediated changes in the cell transcriptome were observed.
- The study found that RNASET2 affects microRNA expression patterns, contributing to its oncosuppressive role.
Conclusions:
- The RNASET2 gene plays a significant cell-autonomous role in ovarian cancer.
- RNASET2 influences ovarian cancer cell transcriptome and microRNA expression.
- These findings provide a deeper understanding of RNASET2's oncosuppressive mechanisms and potential therapeutic applications.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:55The Nucleolus